Differences in classification of COPD patients into risk groups A-D: A cross-sectional study

BMC Research Notes

Volumn 7, Issue 1, 2014, Pages

  Zogg, Stefanie ^a,c   Dürr, Selina ^a   Miedinger, David ^a,b   Steveling, Esther Helen ^b   Maier, Sabrina ^a   Leuppi, Jörg Daniel ^a,b  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

^c ETH ZURICH   (Switzerland)

Author keywords

Chronic obstructive pulmonary disease; COPD assessment test; COPD risk groups; COPD severity grades; Exacerbations; Modified Medical Research Council dyspnea scale; New GOLD 2011 classification

Indexed keywords

AGED; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLASSIFICATION; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; SEVERITY OF ILLNESS INDEX;

AGED; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEVERITY OF ILLNESS INDEX;

EID: 84906932762     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-7-562     Document Type: Article

References (30)

1. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Global initiative for chronic obstructive lung disease, [ http://www.goldcopd.org/uploads/users/files/GOLD-Report-2011-Feb21.pdf ]
2. General practitioner's adherence to the COPD GOLD guidelines: baseline data of the Swiss COPD Cohort Study. Jochmann A, Neubauer F, Miedinger D, Schafroth S, Tamm M, Leuppi JD, Swiss Med Wkly 2010 140 13094
3. Impact of adherence to the GOLD guidelines on symptom prevalence, lung function decline and exacerbation rate in the Swiss COPD cohort. Jochmann A, Scherr A, Jochmann DC, Miedinger D, Torok SS, Chhajed PN, Tamm M, Leuppi JD, Swiss Med Wkly 2012 142 13567
4. Chronic obstructive pulmonary disease-a treatable disease. Osthoff M, Jenkins C, Leuppi JD, Swiss Med Wkly 2013 143 13777
5. Short-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial. Leuppi JD, Schuetz P, Bingisser R, Bodmer M, Briel M, Drescher T, Duerring U, Henzen C, Leibbrandt Y, Maier S, Miedinger D, Muller B, Scherr A, Schindler C, Stoeckli R, Viatte S, von Garnier C, Tamm M, Rutishauser J, JAMA 2013 309 2223 2231
6. Comparisons of health status scores with MRC grades in COPD: implications for the GOLD 2011 classification. Jones PW, Adamek L, Nadeau G, Banik N, Eur Respir J 2013 42 647 654
7. Differences in classification of COPD group using COPD assessment test (CAT) or modified Medical Research Council (mMRC) dyspnea scores: a cross-sectional analyses. Kim S, Oh J, Kim YI, Ban HJ, Kwon YS, Oh IJ, Kim KS, Kim YC, Lim SC, BMC Pulm Med 2013 13 35
8. Prediction of the clinical course of chronic obstructive pulmonary disease, using the new GOLD classification: a study of the general population. Lange P, Marott JL, Vestbo J, Olsen KR, Ingebrigtsen TS, Dahl M, Nordestgaard BG, Am J Respir Crit Care Med 2012 186 975 981
9. Daily physical activity in patients with chronic obstructive pulmonary disease is mainly associated with dynamic hyperinflation. Garcia-Rio F, Lores V, Mediano O, Rojo B, Hernanz A, Lopez-Collazo E, Alvarez-Sala R, Am J Respir Crit Care Med 2009 180 506 512
10. Physical activity in patients with COPD. Watz H, Waschki B, Meyer T, Magnussen H, Eur Respir J 2009 33 262 272
11. Lower limb activity and its determinants in COPD. Walker PP, Burnett A, Flavahan PW, Calverley PM, Thorax 2008 63 683 689
12. Extrapulmonary effects of chronic obstructive pulmonary disease on physical activity: a cross-sectional study. Watz H, Waschki B, Boehme C, Claussen M, Meyer T, Magnussen H, Am J Respir Crit Care Med 2008 177 743 751
13. Daily physical activity, functional capacity and quality of life in patients with COPD. Dürr S, Zogg S, Miedinger D, Steveling EH, Maier S, Leuppi JD, COPD 2014 00 1 8
14. Functional status and well being in chronic obstructive pulmonary disease with regard to clinical parameters and smoking: a descriptive and comparative study. Engström CP, Persson LO, Larsson S, Ryden A, Sullivan M, Thorax 1996 51 825 830
15. Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study. Garcia-Aymerich J, Lange P, Benet M, Schnohr P, Anto JM, Thorax 2006 61 772 778
16. Regular physical activity modifies smoking-related lung function decline and reduces risk of chronic obstructive pulmonary disease: a population-based cohort study. Garcia-Aymerich J, Lange P, Benet M, Schnohr P, Anto JM, Am J Respir Crit Care Med 2007 175 458 463
17. Development and first validation of the COPD assessment test. Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N, Eur Respir J 2009 34 648 654
18. The clinical diagnosis of pulmonary emphysema; an experimental study. Fletcher CM, Proc R Soc Med 1952 45 577 584
19. Evaluation of clinical methods for rating dyspnea. Mahler DA, Wells CK, Chest 1988 93 580 586
20. Standardisation of spirometry. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J, Ats Ers Task Force, Eur Respir J 2005 26 319 338
21. Accuracy of armband monitors for measuring daily energy expenditure in healthy adults. Johannsen DL, Calabro MA, Stewart J, Franke W, Rood JC, Welk GJ, Med Sci Sports Exerc 2010 42 2134 2140
22. Measurement properties of the SenseWear armband in adults with chronic obstructive pulmonary disease. Hill K, Dolmage TE, Woon L, Goldstein R, Brooks D, Thorax 2010 65 486 491
23. Variability in physical activity patterns as measured by the SenseWear Armband: how many days are needed? Scheers T, Philippaerts R, Lefevre J, Eur J Appl Physiol 2012 112 1653 1662
24. Relationship between pulmonary function and physical activity in daily life in patients with COPD. Pitta F, Takaki MY, Oliveira NH, Sant'anna TJ, Fontana AD, Kovelis D, Camillo CA, Probst VS, Brunetto AF, Respir Med 2008 102 1203 1207
25. Obesity and physical activity in the daily life of patients with COPD. Monteiro F, Camillo CA, Vitorasso R, Sant'Anna T, Hernandes NA, Probst VS, Pitta F, Lung 2012 190 403 410
26. The measurement of observer agreement for categorical data. Landis JR, Koch GG, Biometrics 1977 33 159 174
27. Creating scenarios of the impact of COPD and their relationship to COPD Assessment Test (CAT) scores. Jones PW, Tabberer M, Chen WH, BMC Pulm Med 2011 11 42
28. COPD exacerbations: definitions and classifications. Burge S, Wedzicha JA, Eur Respir J Suppl 2003 41 46s 53s
29. Level of daily physical activity in individuals with COPD compared with healthy controls. Vorrink SN, Kort HS, Troosters T, Lammers JW, Respir Res 2011 12 33
30. Validity of activity monitors in health and chronic disease: a systematic review. Van Remoortel H, Giavedoni S, Raste Y, Burtin C, Louvaris Z, Gimeno-Santos E, Langer D, Glendenning A, Hopkinson NS, Vogiatzis I, Peterson BT, Wilson F, Mann B, Rabinovich R, Puhazn MA, Troosters T, PROactive consortium, Int J Behav Nutr Phys Act 2012 9 84